Compare Liquidia Corporation Common Stock (LQDA) vs Nu Holdings Ltd (NU) Price & Performance

Liquidia Corporation Common StockTrade

Nu Holdings LtdTrade

Price performance (Past 24H)

Key statistics

Liquidia Corporation Common Stock vs Nu Holdings Ltd — how do they compare? Liquidia Corporation Common Stock trades at $33.78 (market cap $2.40B), while Nu Holdings Ltd trades at $14.7 (market cap $75.26B). The key difference: Nu Holdings Ltd is far larger — about 31.4× Liquidia Corporation Common Stock's market cap, and Nu Holdings Ltd is trading nearer its 52-week high, Liquidia Corporation Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Liquidia Corporation Common Stock for 0 Days and Nu Holdings Ltd for 53 Days on average.

	LQDA	NU
Market Cap	$2.40B	$75.26B
Volume	2,857,547	60,119,584
Sector	Health	Financials
52-Week High	$91.03	$18.76
52-Week Low	$22.02	$11.60
Typical Hold Time	0 Days	53 Days
Enterprise Value	$2.30B	$97.88B

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Liquidia Corporation Common Stock

No Aura AI signal available yet.

Nu Holdings Ltd

NU stock trades at $14.93, down 6.75% over 24 hours amid recent volatility. The technical outlook is bullish based on moving averages, though the 6-day RSI at 88.3 suggests overbought conditions. Fundamentally, the company shows strong growth with revenue rising from $3.0B in 2022 to $10.63B in 2025 and net income margin improving to 26.99%. Recent news includes denial of Monzo acquisition talks, causing price swings.

The outlook remains positive given robust fundamentals and analyst consensus, but risks include high valuation multiples, credit concentration, and acquisition speculation volatility. Upside to the $16.53 price target offers potential, though investor caution is warranted near technical resistance.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

LQDA

62% Buy38% Sell

Avg holding period · 0 Days

18% Buy82% Sell

Avg holding period · 53 Days

Top news

Latest headlines on both assets

LQDA

Bending Spoons jumps 41% as Berkshire Hathaway boosts stake; Antelope Enterprise and others also surge.Andrew Wynn · 8 hours agoBullish Liquidia shares jump 25% after settling patent lawsuits with United TherapeuticsProactive Investors · 16 hours agoBullish Liquidia settles patent dispute with United Therapeutics, stock jumps 42% despite $380M payout.24/7 Wall Street · 18 hours agoBullish View details →

Nu Holdings shows strong growth and U.S. expansion potential despite market skepticism.Seeking Alpha · 17 hours agoBullish Nu Holdings remains a strong buy amid bold global expansion and market volatility.Seeking Alpha · 21 hours agoBullish View details →

About Liquidia Corporation Common Stock

Liquidia Corporation is a biopharmaceutical company that develops therapies for rare cardiopulmonary diseases, including YUTREPIA, an inhaled treprostinil powder for pulmonary hypertension built on its PRINT technology.

About Nu Holdings Ltd

Nu Holdings Ltd is engaged in providing digital banking services. It offers several financial services such as Credit cards, Personal Account, Investments, Personal Loans, Insurance, Mobile payments, Business Account, and Rewards.